BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program
16 févr. 2022 08h30 HE
|
BioRestorative Therapies, Inc
Notice of Allowance Grants Protection for BioRestorative’s Phase 2 Clinical Program to Treat Chronic Lumbar Disc Disease MELVILLE, N.Y., Feb. 16, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...